Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.600
-0.060 (-3.61%)
Apr 20, 2026, 8:54 AM EDT - Market open
Dogwood Therapeutics Market Cap
Dogwood Therapeutics has a market cap or net worth of $53.44 million as of April 20, 2026. Its market cap has increased by 590.47% in one year.
Market Cap
53.44M
Enterprise Value
49.08M
1-Year Change
590.47%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since December 17, 2020, Dogwood Therapeutics's market cap has decreased from $130.88M to $53.44M, a decrease of -59.17%. That is a compound annual growth rate of -15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 55.45M | -55.16% |
| Dec 31, 2025 | 123.67M | 3,628.17% |
| Dec 31, 2024 | 3.32M | -70.04% |
| Dec 29, 2023 | 11.07M | 155.97% |
| Dec 30, 2022 | 4.33M | -89.85% |
| Dec 31, 2021 | 42.61M | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 60.22M |
| Entera Bio | 59.68M |
| Cue Biopharma | 59.20M |
| OS Therapies | 58.43M |
| Metagenomi Therapeutics | 55.68M |
| Actuate Therapeutics | 54.77M |
| Kezar Life Sciences | 54.03M |
| Mereo BioPharma Group | 53.73M |